Generation of tumor-specific T-cell therapies-Reference-Cited by-同舟云学术

Generation of tumor-specific T-cell therapies

Published:2006-03 Issue:2 Volume:20 Page:61-69
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Morris Emma,Hart Dan,Gao Liquan,Tsallios Aristotle,Xue Shao-an,Stauss Hans

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference63 articles.

1. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity;Shankaran;Nature,2001

2. On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients;van Oijen;Clin Cancer Res,2004

3. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma;Mortarini;Cancer Res,2003

4. The onset and extent of genomic instability in sporadic colorectal tumor progression;Stoler;Proc Natl Acad Sci USA,1999

5. CTLs specific for bcr-abl joining region segment peptides fail to lyse leukemia cells expressing p210 bcr-abl protein;Chen;J Immunother,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR mimic compounds for pHLA targeting with high potency modalities in oncology;Frontiers in Oncology;2022-10-21

2. Engineering Antibodies Targeting p16 MHC-Peptide Complexes;ACS Chemical Biology;2022-02-25

3. Wilms tumor gent 1 (WT1)-specific adoptive immunotherapy in hematologic diseases;International Immunopharmacology;2021-05

4. Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia;Current Cancer Drug Targets;2020-08-11

5. T cell receptor-engineered T cells for leukemia immunotherapy;Cancer Cell International;2019-01-03